MannKind Corporation is a biopharmaceutical company in California that focuses on developing and marketing inhaled therapeutic products for endocrine and lung diseases. Their products currently include Afrezza, an inhaled insulin, and Thyquidity, which treats hypothyroidism in both adults and children. The company also has collaboration agreements with United Therapeutics Corporation and NRx Pharmaceuticals to further develop existing treatments.